Randomized Clinical Trial: Perioperative Rifaximin Is Not Associated with Enhanced Functional and Volumetric Recovery after Major Liver Resection (ARROW). (2022) - Bednarsch, J.; Czigany, Z.; Loosen, S.H.; Heij, L.R.; Ruckgaber, L.; Maes, H.; Krause, J.-P.; Reen, M.; Toteva, B.; Vosdellen, T.; Bruners, P.; Lang, S.A.; et al.